Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2005 3
2006 1
2007 6
2008 3
2009 13
2010 6
2011 2
2012 4
2013 5
2014 14
2015 15
2016 7
2017 11
2018 9
2019 12
2020 20
2021 25
2022 19
2023 18
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Results by year

Filters applied: . Clear all
Page 1
A Th1-like CD4+ T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer.
Yanagihara A, Yamasaki S, Hashimoto K, Taguchi R, Umesaki T, Imai H, Kaira K, Nitanda H, Sakaguchi H, Ishida H, Kobayashi K, Horimoto K, Kagamu H. Yanagihara A, et al. Among authors: imai h. Cancer Res Commun. 2023 Jul 19;3(7):1277-1285. doi: 10.1158/2767-9764.CRC-23-0167. eCollection 2023 Jul. Cancer Res Commun. 2023. PMID: 37476074 Free PMC article.
Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib.
Yamaguchi O, Kasahara N, Soda H, Imai H, Naruse I, Yamaguchi H, Itai M, Taguchi K, Uchida M, Sunaga N, Maeno T, Minato K, Tomono H, Ogawara D, Mukae H, Miura Y, Shiono A, Mouri A, Kagamu H, Kaira K. Yamaguchi O, et al. Among authors: imai h. Sci Rep. 2023 Nov 27;13(1):20848. doi: 10.1038/s41598-023-48210-5. Sci Rep. 2023. PMID: 38012343 Free PMC article.
Recurrent intimal sarcoma mimicking pulmonary embolism.
Kaira K, Imai H, Yamada M. Kaira K, et al. Among authors: imai h. Jpn J Clin Oncol. 2015 Jul;45(7):695-6. doi: 10.1093/jjco/hyv060. Epub 2015 Apr 23. Jpn J Clin Oncol. 2015. PMID: 25910815 No abstract available.
Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: TORG1937 (DATE Study).
Nakamichi S, Kubota K, Misumi T, Kondo T, Murakami S, Shiraishi Y, Imai H, Harada D, Isobe K, Itani H, Takata S, Wakui H, Misumi Y, Ikeda S, Asao T, Furuya N, Hosokawa S, Kobayashi Y, Takiguchi Y, Okamoto H. Nakamichi S, et al. Among authors: imai h. Clin Cancer Res. 2024 Mar 15;30(6):1104-1110. doi: 10.1158/1078-0432.CCR-23-2568. Clin Cancer Res. 2024. PMID: 38165684 Free PMC article. Clinical Trial.
189 results